+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Flu Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
Flu Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
New

Flu Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 210 Pages
  • July 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5918233
Description Jump to:
The global flu vaccines market is poised for significant expansion, driven by growing awareness, increased governmental support, and technological advancements in vaccine production. According to recent analysis, the global flu vaccines market is expected to grow from US$ 6.1 billion in 2025 to US$ 9.8 billion by 2032, registering a healthy CAGR of 7.01% during the forecast period.

Market Insights

Flu vaccines are essential biological agents that stimulate the immune system to produce antibodies against the influenza virus. Administered primarily through intramuscular injections, these vaccines have proven effective in preventing infections and reducing the severity and spread of flu outbreaks globally. The growing popularity of quadrivalent vaccines, which protect against four different flu virus strains, is contributing significantly to market growth.

The flu vaccines market comprises approximately 3.6% of the broader global vaccine market, and its prominence continues to rise. Biotech and pharmaceutical companies are actively investing in improving vaccine effectiveness and extending accessibility in both developed and developing regions.

Market Drivers

The flu vaccines market is being propelled by several key factors:

  • Rising Vaccination Rates: National governments and global organizations such as WHO, GAVI, and PAHO are intensifying public health campaigns to promote flu vaccination.
  • Cost-Effectiveness and Accessibility: In emerging economies like India and China, local manufacturers are producing affordable flu vaccines, enhancing access.
  • Supportive Public Health Goals: Countries like Canada have set ambitious targets for flu vaccination coverage, particularly among high-risk groups.
  • Technological Innovation: Continuous R&D efforts are improving vaccine formulations and delivery methods, including advancements in mRNA-based flu vaccines.

Business Opportunity

The growing global focus on pandemic preparedness and infectious disease prevention is opening new avenues for flu vaccine manufacturers. Increased awareness about the annual flu vaccine’s role in preventing hospitalizations and saving lives is expected to generate substantial revenue opportunities.

For example, according to CDC estimates, flu vaccinations during the 2019-2020 season prevented approximately 105,000 hospitalizations in the United States. Such statistics highlight the economic and healthcare benefits of flu vaccines, reinforcing their value proposition in public health strategies.

Regional Analysis

  • United States: The U.S. dominates the global market, largely due to strong supply chains and high public awareness. Manufacturers are anticipated to deliver over 180 million doses for upcoming flu seasons.
  • Japan: Rising incidents of avian influenza and strict biosecurity measures are pushing demand for flu vaccines.
  • Germany: Expanded national vaccination programs targeting children and high-risk populations are driving market penetration.
  • China: Regulatory advancements and a maturing vaccine production industry are enabling China to emerge as a key contributor to the global market.

Key Players

Leading companies in the flu vaccines market are concentrating on expanding their product portfolios, increasing production capacities, and investing in innovative technologies.
  • Sanofi Pasteur Inc.: Engaged in mRNA-based vaccine development with promising early-phase trial results.
  • AstraZeneca
  • CSL Ltd.
  • Abbott
  • GlaxoSmithKline Plc.
  • Serum Institute of India Pvt. Ltd.: Launched India’s first locally produced quadrivalent HPV vaccine, marking progress in vaccine innovation.

Segmentation

By Product

  • Trivalent Flu Vaccine
  • Quadrivalent Flu Vaccine

By Dosage Form

  • Intramuscular Injection
  • Nasal Spray
  • Intradermal Shot

By Distribution Channel

Institutional Sales

  • Hospitals
  • Community Clinics
  • Public Health Agencies
  • Workplace Purchasing

Retail Sales

  • Retail Pharmacies
  • Mail Order Pharmacies

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Flu Vaccines Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Price Analysis, 2019-2023
3.1. Global Average Price Analysis, by Product/ Application, US$ Per Unit, 2019-2023
3.2. Prominent Factor Affecting Flu Vaccines Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit
4. Global Flu Vaccines Market Outlook, 2019-2032
4.1. Global Flu Vaccines Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Trivalent Flu Vaccine
4.1.1.2. Quadrivalent Flu Vaccine
4.2. Global Flu Vaccines Market Outlook, by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Intramuscular Injection
4.2.1.2. Nasal Spray
4.2.1.3. Intradermal Shot
4.3. Global Flu Vaccines Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Institutional Sales
4.3.1.1.1. Hospitals
4.3.1.1.2. Community Clinics
4.3.1.1.3. Public Health Agencies
4.3.1.1.4. Workplace Purchasing
4.3.1.2. Retail Sales
4.3.1.2.1. Retail Pharmacies
4.3.1.2.2. Mail Order Pharmacies
4.4. Global Flu Vaccines Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.4.1. Key Highlights
4.4.1.1. North America
4.4.1.2. Europe
4.4.1.3. Asia Pacific
4.4.1.4. Latin America
4.4.1.5. Middle East & Africa
5. North America Flu Vaccines Market Outlook, 2019-2032
5.1. North America Flu Vaccines Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Trivalent Flu Vaccine
5.1.1.2. Quadrivalent Flu Vaccine
5.2. North America Flu Vaccines Market Outlook, by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Intramuscular Injection
5.2.1.2. Nasal Spray
5.2.1.3. Intradermal Shot
5.3. North America Flu Vaccines Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Institutional Sales
5.3.1.1.1. Hospitals
5.3.1.1.2. Community Clinics
5.3.1.1.3. Public Health Agencies
5.3.1.1.4. Workplace Purchasing
5.3.1.2. Retail Sales
5.3.1.2.1. Retail Pharmacies
5.3.1.2.2. Mail Order Pharmacies
5.4. North America Flu Vaccines Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1. Key Highlights
5.4.1.1. U.S. Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1.2. U.S. Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1.3. U.S. Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1.4. Canada Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1.5. Canada Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1.6. Canada Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Europe Flu Vaccines Market Outlook, 2019-2032
6.1. Europe Flu Vaccines Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Trivalent Flu Vaccine
6.1.1.2. Quadrivalent Flu Vaccine
6.2. Europe Flu Vaccines Market Outlook, by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Intramuscular Injection
6.2.1.2. Nasal Spray
6.2.1.3. Intradermal Shot
6.3. Europe Flu Vaccines Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Institutional Sales
6.3.1.1.1. Hospitals
6.3.1.1.2. Community Clinics
6.3.1.1.3. Public Health Agencies
6.3.1.1.4. Workplace Purchasing
6.3.1.2. Retail Sales
6.3.1.2.1. Retail Pharmacies
6.3.1.2.2. Mail Order Pharmacies
6.4. Europe Flu Vaccines Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Germany Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.2. Germany Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.3. Germany Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.4. U.K. Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.5. U.K. Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.6. U.K. Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.7. France Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.8. France Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.9. France Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.10. Italy Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.11. Italy Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.12. Italy Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.13. Turkey Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.14. Turkey Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.15. Turkey Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.16. Russia Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.17. Russia Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.18. Russia Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.19. Rest of Europe Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.20. Rest of Europe Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1.21. Rest of Europe Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Asia Pacific Flu Vaccines Market Outlook, 2019-2032
7.1. Asia Pacific Flu Vaccines Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Trivalent Flu Vaccine
7.1.1.2. Quadrivalent Flu Vaccine
7.2. Asia Pacific Flu Vaccines Market Outlook, by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Intramuscular Injection
7.2.1.2. Nasal Spray
7.2.1.3. Intradermal Shot
7.3. Asia Pacific Flu Vaccines Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Institutional Sales
7.3.1.1.1. Hospitals
7.3.1.1.2. Community Clinics
7.3.1.1.3. Public Health Agencies
7.3.1.1.4. Workplace Purchasing
7.3.1.2. Retail Sales
7.3.1.2.1. Retail Pharmacies
7.3.1.2.2. Mail Order Pharmacies
7.4. Asia Pacific Flu Vaccines Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1. Key Highlights
7.4.1.1. China Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.2. China Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.3. China Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.4. Japan Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.5. Japan Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.6. Japan Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.7. South Korea Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.8. South Korea Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.9. South Korea Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.10. India Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.11. India Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.12. India Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.13. Southeast Asia Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.14. Southeast Asia Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.15. Southeast Asia Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.16. Rest of Asia Pacific Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.17. Rest of Asia Pacific Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.18. Rest of Asia Pacific Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Latin America Flu Vaccines Market Outlook, 2019-2032
8.1. Latin America Flu Vaccines Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Trivalent Flu Vaccine
8.1.1.2. Quadrivalent Flu Vaccine
8.2. Latin America Flu Vaccines Market Outlook, by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.2.1.1. Intramuscular Injection
8.2.1.2. Nasal Spray
8.2.1.3. Intradermal Shot
8.3. Latin America Flu Vaccines Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Institutional Sales
8.3.1.1.1. Hospitals
8.3.1.1.2. Community Clinics
8.3.1.1.3. Public Health Agencies
8.3.1.1.4. Workplace Purchasing
8.3.1.2. Retail Sales
8.3.1.2.1. Retail Pharmacies
8.3.1.2.2. Mail Order Pharmacies
8.4. Latin America Flu Vaccines Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Brazil Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.2. Brazil Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.3. Brazil Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.4. Mexico Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.5. Mexico Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.6. Mexico Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.7. Argentina Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.8. Argentina Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.9. Argentina Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.10. Rest of Latin America Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.11. Rest of Latin America Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1.12. Rest of Latin America Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Middle East & Africa Flu Vaccines Market Outlook, 2019-2032
9.1. Middle East & Africa Flu Vaccines Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.1.1. Key Highlights
9.1.1.1. Trivalent Flu Vaccine
9.1.1.2. Quadrivalent Flu Vaccine
9.2. Middle East & Africa Flu Vaccines Market Outlook, by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.2.1. Key Highlights
9.2.1.1. Intramuscular Injection
9.2.1.2. Nasal Spray
9.2.1.3. Intradermal Shot
9.3. Middle East & Africa Flu Vaccines Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.3.1. Key Highlights
9.3.1.1. Institutional Sales
9.3.1.1.1. Hospitals
9.3.1.1.2. Community Clinics
9.3.1.1.3. Public Health Agencies
9.3.1.1.4. Workplace Purchasing
9.3.1.2. Retail Sales
9.3.1.2.1. Retail Pharmacies
9.3.1.2.2. Mail Order Pharmacies
9.4. Middle East & Africa Flu Vaccines Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1. Key Highlights
9.4.1.1. GCC Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.2. GCC Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.3. GCC Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.4. South Africa Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.5. South Africa Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.6. South Africa Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.7. Egypt Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.8. Egypt Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.9. Egypt Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.10. Nigeria Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.11. Nigeria Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.12. Nigeria Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.13. Rest of Middle East & Africa Flu Vaccines Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.14. Rest of Middle East & Africa Flu Vaccines Market by Dosage Form, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1.15. Rest of Middle East & Africa Flu Vaccines Market by Distribution Channel, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Competitive Landscape
10.1. Product vs Dosage Form Heatmap
10.2. Company Market Share Analysis, 2025
10.3. Competitive Dashboard
10.4. Company Profiles
10.4.1. Sanofi Pasteur Inc.
10.4.1.1. Company Overview
10.4.1.2. Product Portfolio
10.4.1.3. Financial Overview
10.4.1.4. Business Strategies and Development
10.4.2. AstraZeneca
10.4.2.1. Company Overview
10.4.2.2. Product Portfolio
10.4.2.3. Financial Overview
10.4.2.4. Business Strategies and Development
10.4.3. Csl Ltd.
10.4.3.1. Company Overview
10.4.3.2. Product Portfolio
10.4.3.3. Financial Overview
10.4.3.4. Business Strategies and Development
10.4.4. Abbott
10.4.4.1. Company Overview
10.4.4.2. Product Portfolio
10.4.4.3. Financial Overview
10.4.4.4. Business Strategies and Development
10.4.5. GlaxoSmithKline Plc.
10.4.5.1. Company Overview
10.4.5.2. Product Portfolio
10.4.5.3. Financial Overview
10.4.5.4. Business Strategies and Development
10.4.6. Serum Institute Of India Pvt.Ltd
10.4.6.1. Company Overview
10.4.6.2. Product Portfolio
10.4.6.3. Financial Overview
10.4.6.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations

Companies Mentioned

  • Sanofi Pasteur Inc.
  • Astrazeneca
  • Csl Ltd.
  • Abbbott
  • Glaxosmithkline Plc.
  • Serum Institute of India Pvt.Ltd

Related Topics

Related Reports

Microneedle Flu Vaccine - Global Strategic Business Report - Product Image

Microneedle Flu Vaccine - Global Strategic Business Report

  • Report
  • 265 Pages
  • Global
From
Microneedle Flu Vaccine Global Market Report 2025 - Product Image

Microneedle Flu Vaccine Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Influenza Vaccine Market 2024-2028 - Product Image

Influenza Vaccine Market 2024-2028

  • Report
  • 168 Pages
  • Global
From
Avian Influenza Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Avian Influenza Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Influenza Vaccine Market by Vaccine Type, Distribution Channel, End User, Age Group, Dosage, Presentation - Global Forecast to 2030 - Product Image

Influenza Vaccine Market by Vaccine Type, Distribution Channel, End User, Age Group, Dosage, Presentation - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.